Systm Wealth Solutions LLC Gilead Sciences, Inc. Transaction History

Systm Wealth Solutions LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $21,218 - $24,487	-336 Reduced 15.36%	1,852 $127 Million
Q1 2024 Apr 26, 2024	BUY	$71.58 - $87.29 $3,579 - $4,364	50 Added 2.34%	2,188 $160 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $54,439 - $61,735	-743 Reduced 25.79%	2,138 $173 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $213,021 - $232,410	2,881 New	2,881 $216 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $837,954 - $1.2 Million	13,446 New	13,446 $1.15 Billion

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Systm Wealth Solutions LLC with notifications on news.